MUSETTE trial was designed to determine whether a higher dose of the currently approved OCREVUS IV 600 mg would provide additional benefit to people living with relapsing multiple sclerosis The trial ...

Pharmacists share four tips for storing your medication if you're planning to embark on a multi-day hike or go on a camping ...

The so-called “Doomsday mom” who’s already been convicted of killing two of her children and conspiring to kill a romantic rival is back on trial in Arizona for conspiring to murder her ...

to two to three times the currently approved 600 mg dose — in slowing disability progression in adults with relapsing multiple sclerosis (MS), according to new data from a Phase 3 clinical study.